☆ 4.7 Article

FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway

CANCER CELL INTERNATIONAL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition

Qingqing Zhou et al.

Summary: Aberrant expression of SNX5 is associated with tumorigenesis, invasion, and metastasis in several human cancers. This study reveals that SNX5 expression is downregulated in ccRCC and is negatively correlated with tumor size, cancer stage, tumor thrombus of inferior vena cava, and poor prognosis. SNX5 inhibits ccRCC cell proliferation and metastasis, and its knockdown increases these activities. Moreover, SNX5 overexpression blocks CD44 internalization and intracellular trafficking, inhibits TGF-beta-induced migration, invasion, and EMT in ccRCC cells.

MOLECULAR THERAPY-ONCOLYTICS (2022)

添加到收藏夹

Article Cell Biology

YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2

Qiqi Cui et al.

Summary: YBX1, a well-known oncoprotein, promotes cell adhesion, migration, and invasion in RCC cells while inhibiting apoptosis. The study revealed that YBX1 regulates RCC cell apoptosis and generation of reactive oxygen species (ROS) via Kindlin-2, suggesting its potential as a prognostic marker and therapeutic target for RCC.

CELL CYCLE (2021)

添加到收藏夹

Article Cell Biology

The Sigma-2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K-AKT-mTOR Signalling Pathway in Renal Cancer

Bo Zhan et al.

Summary: PB28 inhibits tumorigenic behaviors of renal cancer cells by regulating the PI3K-AKT-mTOR signaling pathway and acts as a sensitizer of cisplatin.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway

Shaoxia Fan et al.

Summary: In this study, it was found that ACTL8 is upregulated in TNBC and is associated with poor prognosis. Silencing ACTL8 inhibited proliferation, migration, and invasion while promoting apoptosis in MDA-MB-231 and BT-549 cells. Additionally, silencing ACTL8 suppressed the activation of the PI3K/AKT/mTOR signaling pathway in these cells, indicating a potential mechanism of ACTL8 in TNBC progression.

ONCOTARGETS AND THERAPY (2021)

添加到收藏夹

Article Oncology

High SAA1 Expression Predicts Advanced Tumors in Renal Cancer

Sen Li et al.

Summary: Renal cell carcinoma (RCC) is the most frequent malignant tumor of the kidney, with 30% of patients being diagnosed at an advanced stage. Clear cell renal cell carcinoma (ccRCC) is the most common subtype, and SAA1 has been identified as a potential diagnostic and prognostic marker for advanced ccRCC. Studies show that high levels of SAA1 are associated with poor overall and disease-free survival times in advanced ccRCC patients. Targeting SAA1 may offer a novel therapeutic approach for these patients.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)

Hua-Hui Wu et al.

Summary: This study identified two novel immune-related prognostic biomarkers for ccRCC patients, which showed strong correlation with patient prognosis and could potentially serve as prognostic biomarkers for ccRCC.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Article Cell Biology

Reduced hyaluronan cross-linking induces breast cancer malignancy in a CAF-dependent manner

Guoliang Zhang et al.

Summary: The study revealed that the deficiency of cross-linked HA induced breast cancer malignancy in a CAF-dependent manner, with CAFs restoring high levels of cross-linked HA and inhibiting malignancy through upregulating TSG6. These findings suggest that recovering HA cross-linking may be a potential therapeutic strategy.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor

Johannes Toms et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

添加到收藏夹

Article Oncology

The prognostic significance of fibroblast activation protein-u in human lung adenocarcinoma

Jianlin Shi et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

The role of PI3K/Akt/mTOR signaling in dose-dependent biphasic effects of glycine on vascular development

Kiyomi Tsuji-Tamura et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Samra Turajlic et al.

CELL (2018)

添加到收藏夹

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

添加到收藏夹

Article Oncology

Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/β-catenin pathway

Jiuyang Liu et al.

BMC CANCER (2018)

添加到收藏夹

Article Oncology

Fibroblast Activation Protein-alpha-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade

Xuyang Wen et al.

ONCOLOGY RESEARCH (2017)

添加到收藏夹

Article Oncology

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

Darshan S. Chandrashekar et al.

NEOPLASIA (2017)

添加到收藏夹

Article Oncology

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells

Taiwen Li et al.

CANCER RESEARCH (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery

Zhilong Jia et al.

BMC GENOMICS (2016)

添加到收藏夹

Article Oncology

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling

Xuguang Yang et al.

CANCER RESEARCH (2016)

添加到收藏夹

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Article Medicine, Research & Experimental

Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro

Volker Teichgraeber et al.

ADVANCES IN MEDICAL SCIENCES (2015)

添加到收藏夹

Review Oncology

Fibroblast activation protein α in tumor microenvironment: Recent progression and implications

Fuming Zi et al.

MOLECULAR MEDICINE REPORTS (2015)

添加到收藏夹

Review Oncology

State-of-the-Art Management of Renal Cell Carcinoma

Waleed Fouad Mourad et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Fibroblast Activation Protein (FAP) Is Essential for the Migration of Bone Marrow Mesenchymal Stem Cells through RhoA Activation

Kuei-Min Chung et al.

PLOS ONE (2014)

添加到收藏夹

Article Cell Biology

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma

H. Wang et al.

CELL DEATH & DISEASE (2014)

添加到收藏夹

Article Pathology

Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma

Xing Hua et al.

DIAGNOSTIC PATHOLOGY (2011)

添加到收藏夹

Article Medicine, General & Internal

Expression of seprase in effusions from patients with epithelial ovarian carcinoma

Zhang Meng-zhen et al.

CHINESE MEDICAL JOURNAL (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein α

K Aertgeerts et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.